Residential Retreat for Veterans and First-responders
Examining the Efficacy and Feasibility of a Residential Retreat Program for PTSD in First-responders and Veterans: A Non-randomized Controlled Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Pouria Saffaran, Bsc
- Phone Number: 647-895-7474
- Email: pouria.saffaran@alum.utoronto.ca
Study Locations
-
-
Ontario
-
Niagara-on-the-lake, Ontario, Canada, L0S 1J0
- Recruiting
- Valhalla Project Niagara
-
Contact:
- Pouria Saffaran, Bsc
- Phone Number: 647-895-7474
- Email: pouria.saffaran@alum.utoronto.ca
-
Contact:
- Graham Bettes
- Phone Number: 289-2597758
- Email: grahambettes@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of PTSD, being a military veteran or first-responder, awareness of treating physician about program attendance
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Residential Cohort
Those completing the program in a residential context
|
The program consists of psychoeducational material regarding PTSD, demonstration of various stress management techniques, and social cohesion activities
Other Names:
|
|
Online Cohort
Those completing the program online
|
The program consists of psychoeducational material regarding PTSD, demonstration of various stress management techniques, and social cohesion activities
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptom Management of PTSD Using the Perceived Medical Condition Self-Management Scale
Time Frame: 1-month after completion of the program
|
determining the potential efficacy of the residential program for improving symptom management.
The scale is adapted to reflect participants management of their PTSD symptoms.
Score ranges from 8 to 40.
Higher scores indicate better management.
|
1-month after completion of the program
|
|
Drop-out rate in the Residential Program
Time Frame: at the end of the 5-day residential program for the residential cohort
|
Determining the extent of treatment drop-out in the Residential Program
|
at the end of the 5-day residential program for the residential cohort
|
|
Symptoms of PTSD Indicated by the PTSD Checklist for DSM-5 scale.
Time Frame: 1-month after completion of the program
|
determining the potential efficacy of the residential program for improving PTSD symptoms.
Scores range from 0 to 80. Higher scores indicate more symptoms of PTSD.
|
1-month after completion of the program
|
|
Interpersonal and Intrapersonal Functioning Using the Brief Inventory of Psychosocial Functioning (B-IPF)
Time Frame: 1-month after the completion of the program
|
determining the potential efficacy of the residential program for improving interpersonal and intrapersonal functioning (e.g., relationship with family, ability to manage daily tasks, etc.).
Scores range from 0 to 42.
Higher scores indicate more problems and lower functioning.
|
1-month after the completion of the program
|
|
Drop-out rate in the Online Program
Time Frame: at the end of the 2 month online program for the online cohort.
|
Determining the extent of treatment drop-out in the Online Program
|
at the end of the 2 month online program for the online cohort.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Jaan Reitav, PhD, C.Psych, Canadian Memorial Chiropractic College
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2650
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.